Episode 309: EAU 24 CheckMate-274 - OS for Adjuvant Nivolumab

In the second part of the Uromigos’ EAU coverage, Dr. Matt Galsky describes the OS signal data from CheckMate-274, which analyzed the use of adjuvant nivolumab in patients with muscle-invasive bladder cancer.

Brian, Tom, and Matt also discuss the future of bladder cancer care and research.